Dosing Initiated in Phase I/II Clinical Trial of APR-246 in Ovarian Cancer

News   Apr 17, 2014

 
Dosing Initiated in Phase I/II Clinical Trial of APR-246 in Ovarian Cancer
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE